Hengrui Pharma｜Company, research and product information
Official name：恒瑞医药
Hengrui Pharma's corporate site provides company, research, product and investor information, with a separate route for adverse-event reporting.
Official website
www.hengrui.com
https://www.hengrui.com/
Visit website ↗opens in a new tabThere is no current access observation. OfficialNav does not claim the site was measured as reachable; the server rechecks on click.
Saved websites stay in this browser only. They do not sync across devices and are lost when browser data is cleared.
A pharmaceutical company, not an online clinic
The website identifies Jiangsu Hengrui Pharmaceuticals as its corporate publisher. It is a starting point for company and research information, not a substitute for clinical care, prescriptions or a medicine retailer.
Sources for this section：江苏恒瑞医药股份有限公司
Locate the relevant information channel
The navigation includes company background, research, international activities, products, news and investor relations. The footer separately lists adverse-event reporting and contact information, distinguishing safety feedback from general corporate enquiries.
Sources for this section：江苏恒瑞医药股份有限公司
Choose the section that matches the information needed
Use the company section for background, products for public product information, and investor relations for disclosures. To report a suspected adverse event, locate the dedicated route and read its requirements. OfficialNav does not submit patient or medication information on a visitor’s behalf.
Sources for this section：江苏恒瑞医药股份有限公司
Do not turn corporate information into treatment advice
Research news and product descriptions do not establish an individual treatment plan, availability for purchase or approval in every jurisdiction. Consult qualified medical professionals about care and medication. This page provides no diagnosis, dosing or efficacy recommendation.
Sources for this section：江苏恒瑞医药股份有限公司
Sources
Editorial information and website identity are checked separately. Sources do not imply endorsement of OfficialNav.
Identity evidence and decision record
These are the public materials the identity decision actually cites.
www.hengrui.com
Supporting material · 江苏恒瑞医药股份有限公司 https://www.hengrui.com/
document.title、页面主体名称与页脚署名；恒瑞医药, 实际观察URL与同域首页/返回首页导航相互核对；https://www.hengrui.com/
Original decision record
页面标题恒瑞医药与页脚江苏恒瑞医药股份有限公司对应，关于恒瑞、研发创新、产品和公司披露导航位于同一站点；医药企业身份不等于医院、在线诊疗或药品零售平台。 基于第一方主体自述、导航关系和署名的组合接受，不以可达、HTTPS或搜索排名晋升。完整双语原创介绍按用户任务审核，使用现有行业分类；不推断未核验的地区范围与英文站可用性。media_sha256=null，仅准备未发布库存。
Regional access observations
Measurements load when you open this section. They never determine official identity.
Institutional descriptions, entry notes, identity decisions and access observations remain separate. No endorsement is implied.